ddt has been researched along with Cushing Syndrome in 5 studies
1,1-bis(p-chlorophenyl)-2,2,2-trichloroethane: structure in first source
Cushing Syndrome: A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
WALLACE, EZ | 1 |
SILVERSTEIN, JN | 1 |
VILLADOLID, LS | 1 |
WEISENFELD, S | 2 |
GOLDNER, MG | 1 |
DANOWSKI, TS | 1 |
SARVER, ME | 1 |
MOSES, C | 1 |
BONESSI, JV | 1 |
Greim, H | 1 |
Black, M | 1 |
5 other studies available for ddt and Cushing Syndrome
Article | Year |
---|---|
Cushing's syndrome due to adrenocortical hyperplasia. Treatment with an inhibitor of adrenocortical secretions.
Topics: Cushing Syndrome; DDT; Humans; Hyperplasia | 1961 |
Treatment of advanced malignancy and Cushing's syndrome with DDD.
Topics: Adrenal Cortex; Cushing Syndrome; DDT; Dichlorodiphenyldichloroethane; Humans; Neoplasms | 1962 |
O-P'DDD THERAPY IN CUSHING'S SYNDROME AND IN OBESITY WITH CUSHINGOID CHANGES.
Topics: Adrenocorticotropic Hormone; Blood Chemical Analysis; Carbohydrate Metabolism; Child; Cushing Syndro | 1964 |
[Toxicity and therapeutic utility of DDT and its metabolites].
Topics: Adolescent; Animals; Bilirubin; Cushing Syndrome; DDT; Humans; Hyperbilirubinemia; Liver; Male; Micr | 1970 |
Drugs and the liver.
Topics: Bilirubin; Cushing Syndrome; DDT; Enzyme Induction; Ethanol; Female; Humans; Hyperbilirubinemia; Inf | 1970 |